Christopher GIBSON, DVM PhD, DACVP
Dr. GIBSON is a board certified (ACVP) veterinary pathologist with a unique experience in research pathology, particularly in the efficacy and safety evaluation of gene therapies. Holder of a Ph.D. in Toxicology from Rutgers, The State University of New Jersey, he began his career at Rutgers studying molecular mechanisms of Parkinson disease and collaborating to several research programs in the fields of neurodegenerative diseases and cancer research. Later he joined the discovery pathology groups at Merck Research Labs in California (USA) where he led internal and external programs aiming at evaluating potential clinical biomarkers, validating targets, assessing cross-reactivity and bio distribution assays, as well as cross-species comparisons (mouse, cynomolgus, rhesus, human). Dr. Gibson also collaborated with DUPONT where he evaluated toxicology studies ranging from acute studies to multi-generation studies.
Histology, Cytology, Pathology, Immunohistochemistry, Immunofluorescence, Confocal microscopy, qPCR, Western blot, Laser Capture Microdissection, Cell culture.
Ancuta APREUTESE, DVM PhD, SFAPV
Member of the French Society of Veterinary Pathology (SFAPV) board, Dr Ancuta Apreutese is a specialist in histopathological and immunohistochemical analysis for experimental pathology studies. She has expertise in oncology as well as toxicological assessment on in-vivo models, and particularly xenograft models. Her experience allows her to work for GLP conditions projects and in compliance with regulatory guidelines (OECD, FDA, REACH …).
Toxicology, Good Laboratory Practices (GLP), xenografts, cancerogenicity, immunohistochemistry, pre-clinical studies.
Lev STIMMER, DVM PhD, ECVP
Holder of the European Board from ECVP, Doctor Lev Stimmer is specialized in the conception and the analysis of experimental pathology studies. His expertise fields are neuropathology, cancer pathology, immunotherapy and infectious diseases. He has an extensive experience in efficacy assessment and safety evaluation in the field of cellular and genic biotherapies i.e. viral vectors, stem cells, tissue transplantation… Another part of his expertise is the histopathologic evaluation of animal models, particularly non-human primates, transgenic rodents and xenografts.
Neuropathology, cancer pathology, immunotherapy, gene therapy
Virgile RICHARD, DVM PhD
Doctor Richard‘s works to validate and launch pathological projects enabled him to gain international fame. He is an expert about translational researches on different therapeutic areas: oncology, obesity and metabolic disorders, allergies, infectious diseases, endocrinology, and bone diseases.
Pathological projects, translational researches.
Jordi ALUMA, DVM PhD, ESTP
Member of the Society of Toxicologic Pathologists (STP) and the European Society of Toxicologic Pathology (ESTP), Jordi Aluma has over 30 years of professional experience in veterinary pathology. He has a strong expertise in toxicological pathology for acute, subacute and chronic studies in all species (rodents, Beagle dogs, NZW rabbits, minipigs and Cynomolgus monkeys).
veterinary pathology, toxicological pathology, rabbits, minipigs, Cynomolgus monkeys
Radu APREUTESE, DVM PhD, SFAPV
Member of the French Society of Veterinary Pathology (SFAPV), Dr Radu Apreutese is seasoned with histopathological and immunohistochemical analysis for experimental pathology studies. He has expertise in the analysis of implantable biomaterials biocompatibility as well as toxicological assessment on in-vivo models.
His experience allows him to work for GLP conditions projects and in compliance with regulatory guidelines (OECD, FDA, ECHA, etc.)
Toxicology, Good Laboratory Practices (GLP), Implantable Medical Devices, transgenic mice, pre-clinical studies.